CELL INTELLIGENCE · 肿瘤细胞治疗研究

从全血高效制备 CAR-T 细胞：降低肿瘤治疗成本并提升可及性的可扩展方案

Efficient manufacturing of CAR-T cells from whole blood: a scalable approach to reduce costs and enhance accessibility in cancer therapy.

可从全血中成功制备具有治疗相关剂量的 CD19/CD22 CAR-T 细胞。

CAR-T 细胞剂量分次给药：临床结局的系统综述

Dose fractionation of CAR-T cells. A systematic review of clinical outcomes.

CAR-T 细胞的剂量-反应相关性：临床研究的系统评价

Dose-response correlation for CAR-T cells: a systematic review of clinical studies.